YU103391A - Heterociklicni antraciklinoni i antraciklinski analozi - Google Patents
Heterociklicni antraciklinoni i antraciklinski analoziInfo
- Publication number
- YU103391A YU103391A YU103391A YU103391A YU103391A YU 103391 A YU103391 A YU 103391A YU 103391 A YU103391 A YU 103391A YU 103391 A YU103391 A YU 103391A YU 103391 A YU103391 A YU 103391A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- heterocyclic
- hydrogen
- anthracyclinons
- anthracyclinal
- analysis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/76—Benzo[c]pyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
- C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
- C07D327/06—Six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/72—Benzo[c]thiophenes; Hydrogenated benzo[c]thiophenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
- C07H15/244—Anthraquinone radicals, e.g. sennosides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
- C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Forms Removed On Construction Sites Or Auxiliary Members Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53610790A | 1990-06-11 | 1990-06-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
YU103391A true YU103391A (sh) | 1994-04-05 |
Family
ID=24137175
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU103391A YU103391A (sh) | 1990-06-11 | 1991-06-11 | Heterociklicni antraciklinoni i antraciklinski analozi |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0533744A1 (ja) |
JP (1) | JPH06504034A (ja) |
CN (1) | CN1058781A (ja) |
AP (1) | AP340A (ja) |
AU (1) | AU653348B2 (ja) |
CA (1) | CA2085120A1 (ja) |
CS (1) | CS178691A3 (ja) |
FI (1) | FI925611A (ja) |
HU (1) | HU9203720D0 (ja) |
IE (1) | IE911965A1 (ja) |
IL (1) | IL98460A0 (ja) |
MA (1) | MA22178A1 (ja) |
NZ (1) | NZ238490A (ja) |
PL (1) | PL297164A1 (ja) |
PT (1) | PT97931A (ja) |
WO (1) | WO1991019725A2 (ja) |
YU (1) | YU103391A (ja) |
ZA (1) | ZA914452B (ja) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0659190A1 (en) * | 1992-11-09 | 1995-06-28 | Biochem Pharma Inc | Antineoplastic heteronaphthoquinones |
US5606037A (en) * | 1992-11-09 | 1997-02-25 | Biochem Pharma Inc. | Processes antineoplastic heteronaphthoquinones |
US5736523A (en) * | 1992-11-09 | 1998-04-07 | Biochem Pharma Inc. | Antineoplastic heteronapthoquinones |
AU6672794A (en) * | 1993-11-05 | 1995-05-23 | Biochem Pharma Inc. | Antineoplastic heteronaphthoquinones |
IT1271689B (it) * | 1994-08-04 | 1997-06-04 | Menarini Farma Ind | 8-fluoro-antracicline, loro processi di preparazione e composizioni farmaceutiche che le contengono |
AU2019324170A1 (en) | 2018-08-23 | 2021-02-18 | Seagen, Inc. | Anti-TIGIT antibodies |
CN111087377B (zh) * | 2020-03-19 | 2020-06-26 | 广东省微生物研究所(广东省微生物分析检测中心) | 苯并异色满醌类化合物及其制备方法和应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6030315B2 (ja) * | 1976-06-01 | 1985-07-16 | 三井東圧化学株式会社 | 4−ハロゲノメチルイソクマリン誘導体の製造法 |
JPS52148088A (en) * | 1976-06-01 | 1977-12-08 | Richardson Merrell Inc | 111aminoalkylmorphansridinee 111ols |
GB2067552B (en) * | 1980-01-16 | 1984-02-29 | Erba Farmitalia | Anthracyline derivatives |
JPS60142976A (ja) * | 1983-12-28 | 1985-07-29 | Yoshinori Asakawa | イソクマリン誘導体 |
PH25651A (en) * | 1986-05-21 | 1991-08-21 | Duphar Int Res | New di, tetrahydroisoquinoline derivatives |
JPH01238579A (ja) * | 1988-03-18 | 1989-09-22 | Yamanouchi Pharmaceut Co Ltd | Y−05460m−a物質及びその製造法 |
JPH08112310A (ja) * | 1994-10-18 | 1996-05-07 | New Oji Paper Co Ltd | 使いすておむつ |
-
1991
- 1991-06-10 HU HU9203720A patent/HU9203720D0/hu unknown
- 1991-06-10 WO PCT/CA1991/000208 patent/WO1991019725A2/en not_active Application Discontinuation
- 1991-06-10 IE IE196591A patent/IE911965A1/en unknown
- 1991-06-10 JP JP3510688A patent/JPH06504034A/ja active Pending
- 1991-06-10 PL PL29716491A patent/PL297164A1/xx unknown
- 1991-06-10 AP APAP/P/1991/000278A patent/AP340A/en active
- 1991-06-10 CA CA002085120A patent/CA2085120A1/en not_active Abandoned
- 1991-06-10 AU AU80973/91A patent/AU653348B2/en not_active Ceased
- 1991-06-10 EP EP91910808A patent/EP0533744A1/en not_active Ceased
- 1991-06-11 ZA ZA914452A patent/ZA914452B/xx unknown
- 1991-06-11 IL IL98460A patent/IL98460A0/xx unknown
- 1991-06-11 CN CN91104005A patent/CN1058781A/zh active Pending
- 1991-06-11 YU YU103391A patent/YU103391A/sh unknown
- 1991-06-11 NZ NZ238490A patent/NZ238490A/en unknown
- 1991-06-11 MA MA22453A patent/MA22178A1/fr unknown
- 1991-06-11 PT PT97931A patent/PT97931A/pt not_active Application Discontinuation
- 1991-06-11 CS CS911786A patent/CS178691A3/cs unknown
-
1992
- 1992-12-10 FI FI925611A patent/FI925611A/fi unknown
Also Published As
Publication number | Publication date |
---|---|
PT97931A (pt) | 1992-03-31 |
WO1991019725A3 (en) | 1992-04-30 |
AU8097391A (en) | 1992-01-07 |
FI925611A0 (fi) | 1992-12-10 |
AP9100278A0 (en) | 1991-07-31 |
CN1058781A (zh) | 1992-02-19 |
ZA914452B (en) | 1992-06-24 |
AP340A (en) | 1994-05-13 |
IE911965A1 (en) | 1991-12-18 |
CS178691A3 (en) | 1992-01-15 |
HU9203720D0 (en) | 1993-03-29 |
FI925611A (fi) | 1992-12-10 |
IL98460A0 (en) | 1992-07-15 |
WO1991019725A2 (en) | 1991-12-26 |
JPH06504034A (ja) | 1994-05-12 |
MA22178A1 (fr) | 1991-12-31 |
NZ238490A (en) | 1994-03-25 |
CA2085120A1 (en) | 1991-12-12 |
PL297164A1 (ja) | 1992-10-05 |
EP0533744A1 (en) | 1993-03-31 |
AU653348B2 (en) | 1994-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3270317D1 (en) | Derivatives of amino acids and their therapeutic use | |
NO963053L (no) | Kosmetiske eller farmasöytiske preparater inneholdende mangiferin eller derivater derav | |
MEP24608A (en) | Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same | |
BR9813368A (pt) | Composto, processo para a preparação do mesmo, e uso do mesmo, composição farmacêutica, e, processo para efetuar a imunossupressão. | |
ES2097174T3 (es) | Derivados de la 2-ciclohexan-1-il amina. | |
YU48441B (sh) | Novi linker za bioaktivna sredstva | |
SE8804586D0 (sv) | 1,4-dihydro-4-oxonaftyridinderivat och salter daerav foerfarande foer framstaellning av dessa jaemte antibakteriella medel innefattande dessa | |
BR9609653A (pt) | Compostos e composições farmacêuticas contendo os mesmos | |
ATE164848T1 (de) | 4''-deoxyerythromycinderivate | |
ES2009723A4 (es) | Derivados de acidos biliares, procedimientos para la preparacion de los mismos y composiciones farmaceuticas conteniendolos. | |
FI961507A0 (fi) | Antrasyklinonijohdannaiset ja niiden käyttö amyloidoosissa | |
IL98262A0 (en) | Chromone derivatives and pharmaceutical compositions containing them | |
YU103391A (sh) | Heterociklicni antraciklinoni i antraciklinski analozi | |
BR9407257A (pt) | Composto do tipo bis-naftalimida composição farmacêutica processo para tratamento de um tumor em mamifero uso do composto do tipo bis-naftalimida e processo para a preparação compostos do tipo bis-naftalimida | |
ES2135722T3 (es) | 1,5-benzodiacepinas 5-heterociclicas moduladoras de la cck o de la gastrina. | |
FI831431A0 (fi) | Bensotiazolinfoereningar | |
ES2173195T3 (es) | Derivados de antraciclina. | |
PT96849A (pt) | Processo de preparacao de novos derivados da beta-fenil-iso-serina e de beta-fenil-iso-serina-(2r,2s) | |
NO305399B1 (no) | 2,3-dihydroksypropyl 2-(1-oksoalkyl)amino-2-deoksoglucopyranosider, deres fremstilling og anvendelse | |
FI902901A0 (fi) | Dibenzol/1,5/dioxocin-5-one-derivat, deras anvaendning i laekemedel och foerfarande foer deras framstaellning. | |
NO991581L (no) | N-(benzotiazol-2-yl)piperidin-1-etanaminderivater, deres fremstilling og anvendelse i terapeutiske midler | |
FI852743A0 (fi) | Acetyleniska fenoxipropanolderivat och farmaceutiska kompositioner foer behandling av hypertoni. | |
ATE247955T1 (de) | Selenophen-antitumormittel | |
ES2041050T3 (es) | Un procedimiento para la preparacion de un glicosido de antraciclina. | |
SE9203824L (sv) | Bensofuranylimidazol-derivat, foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande desamma |